Non-invasive assessment of tissue iron overload.
暂无分享,去创建一个
[1] Greg Brown,et al. Observational study of iron overload as assessed by magnetic resonance imaging in an adult population of transfusion‐dependent patients with β thalassaemia: significant association between low cardiac T2* < 10 ms and cardiac events , 2010, Internal medicine journal.
[2] E. Alexopoulou,et al. Assessment of iron distribution between liver, spleen, pancreas, bone marrow, and myocardium by means of R2 relaxometry with MRI in patients with β‐thalassemia major , 2009, Journal of magnetic resonance imaging : JMRI.
[3] T. Coates,et al. Spleen R2 and R2* in iron‐overloaded patients with sickle cell disease and thalassemia major , 2009, Journal of magnetic resonance imaging : JMRI.
[4] M. Cappellini,et al. Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia , 2008, Haematologica.
[5] T. Coates,et al. Longitudinal analysis of heart and liver iron in thalassemia major. , 2008, Blood.
[6] T. Coates,et al. Magnetic resonance detection of kidney iron deposition in sickle cell disease: A marker of chronic hemolysis , 2008, Journal of magnetic resonance imaging : JMRI.
[7] D. Pennell,et al. One‐stop measurement of iron deposition in the anterior pituitary, liver, and heart in thalassemia patients , 2008, Journal of magnetic resonance imaging : JMRI.
[8] T. Coates,et al. Onset of cardiac iron loading in pediatric patients with thalassemia major , 2008, Haematologica.
[9] W. Au,et al. A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major , 2008, Haematologica.
[10] E. Vichinsky,et al. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients , 2007, Pediatric blood & cancer.
[11] A. Karantanas,et al. Bone marrow changes in beta-thalassemia major: quantitative MR imaging findings and correlation with iron stores , 2007, European Radiology.
[12] Nathalie Boddaert,et al. Selective iron chelation in Friedreich ataxia: biologic and clinical implications. , 2007, Blood.
[13] L. Astrakas,et al. Liver, bone marrow, pancreas and pituitary gland iron overload in young and adult thalassemic patients: a T2 relaxometry study , 2007, European Radiology.
[14] D. Farrell,et al. Liver Iron Susceptometry , 2007 .
[15] A. Piga,et al. Monitoring Long‐Term Efficacy of Iron Chelation Treatment with Biomagnetic Liver Susceptometry , 2005, Annals of the New York Academy of Sciences.
[16] D. Tsiapras,et al. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with β‐thalassemia major , 2005, European journal of haematology.
[17] N. Gourtsoyiannis,et al. Adrenal glands in beta-thalassemia major: magnetic resonance (MR) imaging features and correlation with iron stores , 2005, European Radiology.
[18] T. Coates,et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. , 2005, Blood.
[19] Thomas D. Coates,et al. Cardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron Cardiomyopathy , 2005, Circulation.
[20] Huaqing Zhao,et al. 1/T2 and magnetic susceptibility measurements in a gerbil cardiac iron overload model. , 2005, Radiology.
[21] T. S. St. Pierre,et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. , 2005, Blood.
[22] Yu-Chung N. Cheng,et al. Susceptibility weighted imaging (SWI) , 2004, Zeitschrift fur medizinische Physik.
[23] D. Pennell,et al. A single breath‐hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload , 2003, Journal of magnetic resonance imaging : JMRI.
[24] H. Eiskjaer,et al. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. , 2003, Blood.
[25] H. Cario,et al. Insulin sensitivity and β-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test , 2003, European Journal of Pediatrics.
[26] D N Firmin,et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.
[27] F. Jensen,et al. Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.
[28] M. Kami,et al. Hepatic iron concentration and total body iron stores in thalassemia major. , 2000, The New England journal of medicine.
[29] T. S. St. Pierre,et al. Quantitative mapping of transverse relaxivity (1/T(2)) in hepatic iron overload: a single spin-echo imaging methodology. , 2000, Magnetic resonance imaging.
[30] R. Fischer,et al. Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry , 1999, American journal of hematology.
[31] G. Brittenham,et al. Iron-chelating therapy and the treatment of thalassemia. , 1997, Blood.
[32] C. McLaren,et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. , 1994, The New England journal of medicine.
[33] K. Batts,et al. Liver biopsy diagnosis of homozygous hemochromatosis: a diagnostic algorithm. , 1993, Mayo Clinic proceedings.
[34] J. Hazell,et al. Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosage , 1989, British journal of haematology.
[35] W. Stremmel,et al. Survival and Causes of Death in Hemochromatosis , 1988 .
[36] J. Tripp,et al. Magnetic-susceptibility measurement of human iron stores. , 1982, The New England journal of medicine.
[37] J. H. Tripp,et al. Magnetic measurement of human iron stores , 1980 .
[38] W. Roberts,et al. Iron in the heart. Etiology and clinical significance. , 1971, The American journal of medicine.
[39] Roger Williams,et al. Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis. , 2005, American journal of clinical pathology.
[40] A. Cnaan,et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. , 2004, Haematologica.
[41] G. Brittenham,et al. Noninvasive measurement of iron: report of an NIDDK workshop. , 2003, Blood.
[42] Peter A. Rinck,et al. Magnetic Resonance in Medicine , 1993 .
[43] W. Stremmel,et al. Survival and causes of death in hemochromatosis. Observations in 163 patients. , 1988, Annals of the New York Academy of Sciences.